FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130884024> ?p ?o ?g. }

• W2130884024 endingPage "458" @default.
• W2130884024 startingPage "455" @default.
• W2130884024 abstract "We describe the results of 37 myeloma patients who received bortezomib following reduced intensity allogeneic stem cell transplantation (RIC-allo-SCT). Grade 1-2 peripheral neuropathy (35%), mild thrombocytopenia (24%) and fatigue (19%) were the most frequent adverse events, while there was no worsening of graft-vs-host disease symptoms. Twenty-seven patients (73%; 95% CI, 59-87%) achieved an objective response. With a median follow-up of 9 months from bortezomib initiation, the estimate of overall survival was 65% at 18 months while this was significantly higher (p=0.002) in the 27 patients achieving an objective response, suggesting that bortezomib is a safe and efficient option for myeloma patients after RIC-allo-SCT." @default.
• W2130884024 created "2016-06-24" @default.
• W2130884024 creator A5000359788 @default.
• W2130884024 creator A5001266472 @default.
• W2130884024 creator A5019277748 @default.
• W2130884024 creator A5020301140 @default.
• W2130884024 creator A5020369336 @default.
• W2130884024 creator A5020996390 @default.
• W2130884024 creator A5022161221 @default.
• W2130884024 creator A5045967298 @default.
• W2130884024 creator A5058925624 @default.
• W2130884024 creator A5062694494 @default.
• W2130884024 creator A5072027146 @default.
• W2130884024 creator A5074217417 @default.
• W2130884024 creator A5082189560 @default.
• W2130884024 date "2008-03-01" @default.
• W2130884024 modified "2023-10-06" @default.
• W2130884024 title "High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma" @default.
• W2130884024 cites W1978377409 @default.
• W2130884024 cites W1982412132 @default.
• W2130884024 cites W1990614933 @default.
• W2130884024 cites W2010766702 @default.
• W2130884024 cites W2057831000 @default.
• W2130884024 cites W2072252677 @default.
• W2130884024 cites W2086596596 @default.
• W2130884024 cites W2087613277 @default.
• W2130884024 cites W2089434243 @default.
• W2130884024 cites W2117758623 @default.
• W2130884024 cites W2118820477 @default.
• W2130884024 cites W2122021478 @default.
• W2130884024 cites W2122277484 @default.
• W2130884024 cites W2128659799 @default.
• W2130884024 cites W2133590829 @default.
• W2130884024 cites W2147082411 @default.
• W2130884024 cites W2155988805 @default.
• W2130884024 cites W2185967502 @default.
• W2130884024 cites W2324565208 @default.
• W2130884024 cites W2333363976 @default.
• W2130884024 doi "https://doi.org/10.3324/haematol.12184" @default.
• W2130884024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18287132" @default.
• W2130884024 hasPublicationYear "2008" @default.
• W2130884024 type Work @default.
• W2130884024 sameAs 2130884024 @default.
• W2130884024 citedByCount "59" @default.
• W2130884024 countsByYear W21308840242012 @default.
• W2130884024 countsByYear W21308840242013 @default.
• W2130884024 countsByYear W21308840242014 @default.
• W2130884024 countsByYear W21308840242015 @default.
• W2130884024 countsByYear W21308840242016 @default.
• W2130884024 countsByYear W21308840242017 @default.
• W2130884024 countsByYear W21308840242018 @default.
• W2130884024 countsByYear W21308840242019 @default.
• W2130884024 countsByYear W21308840242020 @default.
• W2130884024 countsByYear W21308840242021 @default.
• W2130884024 crossrefType "journal-article" @default.
• W2130884024 hasAuthorship W2130884024A5000359788 @default.
• W2130884024 hasAuthorship W2130884024A5001266472 @default.
• W2130884024 hasAuthorship W2130884024A5019277748 @default.
• W2130884024 hasAuthorship W2130884024A5020301140 @default.
• W2130884024 hasAuthorship W2130884024A5020369336 @default.
• W2130884024 hasAuthorship W2130884024A5020996390 @default.
• W2130884024 hasAuthorship W2130884024A5022161221 @default.
• W2130884024 hasAuthorship W2130884024A5045967298 @default.
• W2130884024 hasAuthorship W2130884024A5058925624 @default.
• W2130884024 hasAuthorship W2130884024A5062694494 @default.
• W2130884024 hasAuthorship W2130884024A5072027146 @default.
• W2130884024 hasAuthorship W2130884024A5074217417 @default.
• W2130884024 hasAuthorship W2130884024A5082189560 @default.
• W2130884024 hasBestOaLocation W21308840241 @default.
• W2130884024 hasConcept C126322002 @default.
• W2130884024 hasConcept C141071460 @default.
• W2130884024 hasConcept C143998085 @default.
• W2130884024 hasConcept C194409129 @default.
• W2130884024 hasConcept C197934379 @default.
• W2130884024 hasConcept C2776364478 @default.
• W2130884024 hasConcept C2776694085 @default.
• W2130884024 hasConcept C2777408962 @default.
• W2130884024 hasConcept C2777478702 @default.
• W2130884024 hasConcept C2779972918 @default.
• W2130884024 hasConcept C2780775027 @default.
• W2130884024 hasConcept C2911091166 @default.
• W2130884024 hasConcept C71924100 @default.
• W2130884024 hasConcept C90924648 @default.
• W2130884024 hasConceptScore W2130884024C126322002 @default.
• W2130884024 hasConceptScore W2130884024C141071460 @default.
• W2130884024 hasConceptScore W2130884024C143998085 @default.
• W2130884024 hasConceptScore W2130884024C194409129 @default.
• W2130884024 hasConceptScore W2130884024C197934379 @default.
• W2130884024 hasConceptScore W2130884024C2776364478 @default.
• W2130884024 hasConceptScore W2130884024C2776694085 @default.
• W2130884024 hasConceptScore W2130884024C2777408962 @default.
• W2130884024 hasConceptScore W2130884024C2777478702 @default.
• W2130884024 hasConceptScore W2130884024C2779972918 @default.
• W2130884024 hasConceptScore W2130884024C2780775027 @default.
• W2130884024 hasConceptScore W2130884024C2911091166 @default.
• W2130884024 hasConceptScore W2130884024C71924100 @default.
• W2130884024 hasConceptScore W2130884024C90924648 @default.
• W2130884024 hasIssue "3" @default.

• next